News
Sun Pharmaceutical Industries stock ended 2.15 per cent higher on Friday after zooming by almost 5 per cent in the morning ...
Sun Pharma successfully removed an injunction in the US on the launch of its Leqselvi for alopecia areata, a common form of hair loss, that was sought by rival Incyte. The decision in the US Court ...
Deal-making news last week included US drug developer KalVista Pharma signing a licensing agreement with Kaken Pharma to market its investigational hereditary angioedema (HAE) drug sebetralstat in ...
A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...
22h
MedPage Today on MSNPhototherapy Promising as Add-On to Oral Ritlecitinib for VitiligoAdding narrowband ultraviolet B (UVB) phototherapy to oral treatment with ritlecitinib (Litfulo) enhanced repigmentation in ...
As per Vantage Market Research, the Global Plasma Therapy Market has steadily grown over the years due to its potential to ...
Telma 40 is manufactured by Glenmark Pharmaceuticals and is prescribed for controlling high blood pressure, particularly in ...
Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.
Sun Ten Pharmaceutical has established itself as a leading global manufacturer of high-quality herbal remedies by merging traditional Chinese medicine with modern pharmaceutical science. Now, it is ...
Sun Pharmaceutical Industries Ltd. 524715 shares rallied 1.04% to 1,705.15 Indian rupees Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the BSE ...
Shares of major Indian pharmaceutical companies on Wednesday, including Aurobindo Pharma, Sun Pharmaceutical Industries (Sun Pharma), Zydus Lifesciences, Dr. Reddy's Laboratories, Gland Pharma and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results